LPS restores protective immunity in macrophages against Mycobacterium tuberculosis via autophagy

Fang Fang,Qing Ge,Rui Li,Jingzhu Lv,Yao Zhang,Anlin Feng,Gabriel T. Kelly,Hongtao Wang,Xiaojing Wang,Chuanwang Song,Ting Wang,Zhongqing Qian
DOI: https://doi.org/10.1016/j.molimm.2020.05.001
IF: 4.174
2020-08-01
Molecular Immunology
Abstract:<p>Autophagy has been identified as an important immune regulatory mechanism. Recent studies have linked macrophage autophagy with innate immune responses against <em>Mycobacterium tuberculosis</em> (<em>M. tuberculosis</em>), which can survive within macrophages by blocking fusion of the phagosome with lysosomes. These findings suggest that autophagy is a regulatable cellular mechanism of <em>M. tuberculosis</em> defense in macrophages. Transcriptomic profiles in human blood in TB patients suggest that <em>M. tuberculosis</em> affects autophagy related pathways. In order to better understand the role of macrophage autophagy in enhancing protective immunity against <em>M. tuberculosis</em>, in this study, we investigate the effects of the autophagy activators rapamycin and LPS in macrophage autophagy and immunity against <em>M. tuberculosis</em>. We confirm that rapamycin and LPS induce autophagy in <em>M. tuberculosis</em> infected THP-1-derived macrophages or PMA primed THP-1 macrophages [THP-1(A)]. LPS restores <em>M. tuberculosis</em>-inhibited IL-12 synthesis and secretion in THP-1(A) cells via autophagy. Similarly, autophagy activators increase IL-12 synthesis and secretion in THP-1(A) cells. These studies demonstrate the importance of autophagy in <em>M. tuberculosis</em> elimination in macrophages and may lead to novel therapies for tuberculosis and other bacterial infections.</p>
biochemistry & molecular biology,immunology
What problem does this paper attempt to address?
This paper aims to explore the role of autophagy in promoting the protective immunity of macrophages against Mycobacterium tuberculosis (M. tuberculosis). Specifically, the study attempts to address the following key issues: 1. **The impact of tuberculosis on the autophagy pathway**: By analyzing the gene expression profiles in the blood of tuberculosis patients, the study found that tuberculosis affects the gene expression pathways related to autophagy. This indicates that tuberculosis may lead to the dysregulation of autophagy function. 2. **The activation effect of LPS and rapamycin on autophagy**: The study verified whether LPS (lipopolysaccharide) and rapamycin (Rapamycin) can activate the autophagy process in macrophages infected with Mycobacterium tuberculosis. The experimental results showed that LPS and rapamycin can indeed induce the formation of autophagosomes and increase the expression level of LC3 - II protein. 3. **The ability of LPS to restore the killing ability of macrophages against Mycobacterium tuberculosis**: The study further explored whether LPS can restore the killing ability of macrophages against Mycobacterium tuberculosis by activating autophagy. The results showed that LPS significantly reduced the number of live bacteria in infected cells, thereby enhancing the antibacterial function of macrophages. 4. **The role of LPS in up - regulating IL - 12 expression**: The study also examined the effect of LPS on IL - 12 expression. IL - 12 is an important cytokine that can activate the defense mechanisms of macrophages. The experimental results showed that LPS not only up - regulated the mRNA expression level of IL - 12, but also increased the secretion of the active IL - 12 heterodimer protein (IL - 12p70). In addition, the autophagy inhibitor 3 - MA can significantly reduce LPS - induced IL - 12 expression and secretion, which further confirms the important role of autophagy in LPS - activated IL - 12. In summary, this paper mainly addresses the problem of how to enhance the protective immune response of macrophages against Mycobacterium tuberculosis by activating autophagy. These findings not only deepen our understanding of the immunomodulatory mechanisms of macrophages, but also may provide new ideas for the development of new anti - tuberculosis therapies.